Order Article Reprints

Khan T, He Y, Kryza T, Harrington BS, Gunter JH, Sullivan MA, Cuda T, Rogers R, Davies CM, Broomfield A, et al. Disruption of Glycogen Utilization Markedly Improves the Efficacy of Carboplatin against Preclinical Models of Clear Cell Ovarian Carcinoma. Cancers. 2020; 12(4):869. https://doi.org/10.3390/cancers12040869

Khan, Tashbib, Yaowu He, Thomas Kryza, Brittney S. Harrington, Jennifer H. Gunter, Mitchell A. Sullivan, Tahleesa Cuda, Rebecca Rogers, Claire M. Davies, Amy Broomfield, and et al. 2020. "Disruption of Glycogen Utilization Markedly Improves the Efficacy of Carboplatin against Preclinical Models of Clear Cell Ovarian Carcinoma" Cancers 12, no. 4: 869. https://doi.org/10.3390/cancers12040869

Khan, T., He, Y., Kryza, T., Harrington, B. S., Gunter, J. H., Sullivan, M. A., Cuda, T., Rogers, R., Davies, C. M., Broomfield, A., Gough, M., Wu, A. C., McGann, T., Weroha, S. J., Haluska, P., Forbes, J. M., Armes, J. E., Barry, S. C., Coward, J. I., ... Hooper, J. D. (2020). Disruption of Glycogen Utilization Markedly Improves the Efficacy of Carboplatin against Preclinical Models of Clear Cell Ovarian Carcinoma. Cancers, 12(4), 869. https://doi.org/10.3390/cancers12040869